Article
Cost-Utility of Dalbavancin as a Treatment Option for Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Canada
2024-11-07
Abstract excerpt
<h4>Background: </h4> /Objectives: The standard of care for acute bacterial skin and skin structure infections (ABSSSIs) requiring intravenous (IV) antibiotics includes vancomycin, administered over several days, in a hospital or outpatient setting resulting in significant costs. Dalbavancin, a long-acting single-dose lipoglycopeptide IV therapy may offer a cost-effective option for adult patients with ABSSSIs in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 791d594a-125e-5b1c-bfa3-4d324c9f938f
- DOI
- 10.20944/preprints202411.0514.v1
